Short-Term Surgical Outcomes of Robotic Gastrectomy Compared to Open Gastrectomy for Patients with Gastric Cancer: a Randomized Trial

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
JOURNAL OF GASTROINTESTINAL SURGERY, v.26, n.12, p.2477-2485, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Robotic gastrectomy (RG) has been shown to be a safe and feasible method in gastric cancer (GC) treatment. However, most studies are in Eastern cohorts and there is great interest in knowing whether the method can be used routinely, especially in the West. Objectives The aim of this study was to compare the short-term surgical outcomes of D2-gastrectomy by RG versus open gastrectomy (OG). Methods Single-institution, open-label, non-inferiority, randomized clinical trial performed between 2015 and 2020. GC patients were randomized (1:1 allocation) to surgical treatment by RG or OG. Da Vinci Si platform was used. Inclusion criteria: gastric adenocarcinoma, stage cT2-4 cNO-1, potentially curative surgery, age 18-80 years, and ECOG performance status 0-1. Exclusion criteria: emergency surgery and previous gastric or major abdominal surgery. Primary endpoint was short-term surgical outcomes. The study is registered at clinicaltrials.gov (NCT02292914). Results Of 65 randomized patients, 5 were excluded (3 palliatives, 1 obstruction and emergency surgery, and 1 for material shortage). Consequently, 31 and 29 patients were included for final analysis in the OG and RG groups, respectively. No differences were observed between groups regarding age, sex, BMI, comorbidities, ASA, and frequency of total gastrectomy. RG had similar mean number of harvested lymph nodes (p = 0.805), longer surgical time (p < 0.001), and less bleeding (p <0.001) compared to OG. Postoperative complications, length of hospital stay, and readmissions in 30 days were equivalent between OG and RG. Conclusions RG reduces operative bleeding by more than 50%. The short-term outcomes were non-inferior to OG, although surgical time was longer in RG.
Palavras-chave
Gastric cancer, Randomized clinical trial, Robotic surgery, Open surgery, DaVinci system, Short-term surgical outcome
Referências
  1. Aiolfi A, 2021, SURGERY, V170, P942, DOI 10.1016/j.surg.2021.04.014
  2. Ali BI, 2016, J GASTRIC CANCER, V16, P28, DOI 10.5230/jgc.2016.16.1.28
  3. Chen L, 2022, ASIAN J SURG, V45, P698, DOI 10.1016/j.asjsur.2021.07.069
  4. Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2
  5. Dias AR, 2020, ABCD-ARQ BRAS CIR DI, V33, DOI 10.1590/0102-672020200003e1542
  6. Dias AR, 2016, GASTRIC CANCER, V19, P136, DOI 10.1007/s10120-014-0443-2
  7. Hu YF, 2016, J CLIN ONCOL, V34, P1350, DOI 10.1200/JCO.2015.63.7215
  8. Huang CM, 2022, JAMA SURG, V157, P9, DOI 10.1001/jamasurg.2021.5104
  9. In H, 2017, ANN SURG ONCOL, V24, P3683, DOI 10.1245/s10434-017-6078-x
  10. Japanese Gastric Canc Assoc, 2017, GASTRIC CANCER, V20, P1, DOI [10.1007/s10120-016-0622-4, 10.1007/s10120-020-01042-y]
  11. Jiang XH, 2012, ANN SURG ONCOL, V19, P115, DOI 10.1245/s10434-011-1893-y
  12. Kang SY, 2010, J GASTRIC CANCER, V10, P247, DOI 10.5230/jgc.2010.10.4.247
  13. Katai H, 2017, GASTRIC CANCER, V20, P699, DOI 10.1007/s10120-016-0646-9
  14. Katai H, 2010, GASTRIC CANCER, V13, P238, DOI 10.1007/s10120-010-0565-0
  15. Kim HI, 2016, ANN SURG, V263, P103, DOI 10.1097/SLA.0000000000001249
  16. Kim HH, 2019, JAMA ONCOL, V5, P506, DOI 10.1001/jamaoncol.2018.6727
  17. Kim MS, 2021, ANN SURG, V273, P949, DOI 10.1097/SLA.0000000000003583
  18. Ramos MFKP, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e543s
  19. Lee HJ, 2019, ANN SURG, V270, P983, DOI 10.1097/SLA.0000000000003217
  20. Lu J, 2021, ANN SURG, V273, P858, DOI 10.1097/SLA.0000000000004466
  21. Ma JL, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-02080-7
  22. Marano L, 2021, UPDATES SURG, V73, P865, DOI 10.1007/s13304-020-00896-2
  23. Martin AN, 2016, J GASTROINTEST SURG, V20, P1554, DOI 10.1007/s11605-016-3195-y
  24. Ojima T, 2021, JAMA SURG, V156, P954, DOI 10.1001/jamasurg.2021.3182
  25. Papenfuss WA, 2014, ANN SURG ONCOL, V21, P3008, DOI 10.1245/s10434-014-3664-z
  26. Park JM, 2008, SURG ENDOSC, V22, P2133, DOI 10.1007/s00464-008-9962-4
  27. Waki Yuhei, 2018, Gan To Kagaku Ryoho, V45, P1690
  28. Yasunaga H, 2013, ANN SURG, V257, P640, DOI 10.1097/SLA.0b013e31826fd541
  29. Zhang YR, 2019, GEN PSYCHIAT, V32, DOI 10.1136/gpsych-2019-100069
  30. Zheng BB, 2019, SURG ENDOSC, V33, P1033, DOI 10.1007/s00464-018-06648-z